afreeze GmbH

afreeze is a privately owned European company, founded to develop medical devices for the treatment of heart rhythm diseases by using cryoenergy.
Based on a scientifically proven and generally acknowledged source of cryoenergy, afreeze has created the innovative coolloop® catheter. The system enables the physician to create circumferential lesions in the affected heart tissue, providing a new therapeutic option to treat atrial fibrillation. This intervention, known as left atrial ablation, is a well-known and safe method that can release patients from lifelong medicinal therapy, thus improving their everday’s quality of life tremendously.
To understand how the coolloop®-system works, afreeze is a privately owned European company, founded to develop medical devices for the treatment of heart rhythm diseases by using cryoenergy.
Based on a scientifically proven and generally acknowledged source of cryoenergy, afreeze has created the innovative coolloop® catheter. The system enables the physician to create circumferential lesions in the affected heart tissue, providing a new therapeutic option to treat atrial fibrillation. This intervention, known as left atrial ablation, is a well-known and safe method that can release patients from lifelong medicinal therapy, thus improving their everday’s quality of life tremendously.
To learn more about afreeze and the coolloop®-system, see our website.

Company’s Keywords:

cryoablation for cardiac arrhythmias